As trials expand into new geographies and decentralized models mature, sponsors are confronting a core operational challenge in 2026: how to scale global execution while reducing system complexity and ...

In today’s ACT Brief, we examine how large de-identified datasets are reshaping trial design and site strategy, why global ...

Targeted therapies for MASH show progress, with pegozafermin leading in efficacy for fibrosis regression and disease resolution. New research highlights the effectiveness of targeted therapies for ...

TORONTO, April 3, 2025 /CNW/ - NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming ...

Clinical trial design decisions impact costs, access, and evidence gaps, with breast cancer as the most studied disease globally. The US leads in trial activity, with China showing rapid growth, ...

Clinical trials often suffer from a lack of participant diversity, resulting in findings that may not fully represent the eventual treated patient population. This issue has improved only modestly in ...

GSK and Genomics plc will collaborate on a new precision medicine initiative that assesses how genetic data can be used in clinical trial design, Genomics announced April 30. The project will look at ...

An inter-organizational group of researchers and administrators from Case CCC recently published their work, "Impact of clinical trial design on recruitment of racial and ethnic minorities," in the ...

Note: This is the third article of a three-part series. Real-world evidence (RWE) plays a crucial role in supporting the benefits of one drug over another in debates that play out on the boards and ...

Forbes contributors publish independent expert analyses and insights. I write about the application of AI & Big Data to innovation and prediction. Feb 22, 2024, 03:42am EST Clinical trials are ...

Eli Lilly believes community-based clinical trials are the wave of the future and is pushing sponsors to embrace the paradigm as a way to boost enrollment and diversity. “In the future, I think we’ll ...